One possible explanation is that high stromal Cav-1 levels allow for increased nab-paclitaxel uptake in stromal cells and tissue, which competitively reduce the uptake of nab-paclitaxel in the breast cancer cells. The gene discussed is CAV1; the disease is breast cancer.